Haleon PLC (HLN)
9.55
+0.07
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
9.60
+0.05
(+0.52%)
Pre-Market: 05:28
Haleon Shareholders Equity (Quarterly): 21.00B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 21.00B |
| December 31, 2023 | 21.15B |
| June 30, 2023 | 20.75B |
| Date | Value |
|---|---|
| December 31, 2022 | 19.76B |
| June 30, 2022 | 32.62B |
| December 31, 2021 | 35.57B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.76B
Minimum
Dec 2022
35.57B
Maximum
Dec 2021
25.14B
Average
21.08B
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| GSK PLC | 18.75B |
| Smith & Nephew PLC | 5.205B |
| Adaptimmune Therapeutics PLC | 79.99M |
| Biodexa Pharmaceuticals PLC | 11.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.24B |
| Total Liabilities (Quarterly) | 21.11B |
| Debt to Equity Ratio | 0.5263 |
| Current Ratio | 0.8375 |
| Net Debt Paydown Yield | 5.08% |